BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28350138)

  • 1. miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer.
    Wang X; Guo H; Yao B; Helms J
    Oncol Rep; 2017 May; 37(5):2720-2726. PubMed ID: 28350138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
    Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J
    Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma.
    Lin XJ; He CL; Sun T; Duan XJ; Sun Y; Xiong SJ
    Int J Mol Med; 2017 Jul; 40(1):83-89. PubMed ID: 28535002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway.
    Su X; Wang J; Chen W; Li Z; Fu X; Yang A
    Oncotarget; 2016 Mar; 7(9):9939-50. PubMed ID: 26799420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
    Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma.
    Liu M; Wang J; Huang H; Hou J; Zhang B; Wang A
    Biochem Biophys Res Commun; 2013 Nov; 441(2):364-70. PubMed ID: 24148247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
    Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
    Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-373-3p Targets DKK1 to Promote EMT-Induced Metastasis via the Wnt/
    Weng J; Zhang H; Wang C; Liang J; Chen G; Li W; Tang H; Hou J
    Biomed Res Int; 2017; 2017():6010926. PubMed ID: 28337453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist.
    Peng F; Zhang H; Du Y; Tan P
    Oncol Rep; 2015 Feb; 33(2):942-50. PubMed ID: 25501015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4.
    Ren W; Wang X; Gao L; Li S; Yan X; Zhang J; Huang C; Zhang Y; Zhi K
    Mol Cell Biochem; 2014 May; 390(1-2):253-62. PubMed ID: 24609942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation.
    Chen W; Wang P; Lu Y; Jin T; Lei X; Liu M; Zhuang P; Liao J; Lin Z; Li B; Peng Y; Pan G; Lv X; Zhang H; Ou Z; Xie S; Lin X; Sun S; Ferrone S; Tannous BA; Ruan Y; Li J; Fan S
    Theranostics; 2019; 9(20):5739-5754. PubMed ID: 31534516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-940 inhibits migration and invasion of tongue squamous cell carcinoma via regulatingCXCR2/NF-κB system-mediated epithelial-mesenchymal transition.
    Ma T; Zhao Z; Wang Z; Wang C; Zhang L
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1359-1369. PubMed ID: 31214736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.
    Li D; Liu K; Li Z; Wang J; Wang X
    Cell Adh Migr; 2018 May; 12(3):236-246. PubMed ID: 29130787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-203 inhibits cell proliferation and promotes cisplatin induced cell death in tongue squamous cancer.
    Lin J; Lin Y; Fan L; Kuang W; Zheng L; Wu J; Shang P; Wang Q; Tan J
    Biochem Biophys Res Commun; 2016 Apr; 473(2):382-7. PubMed ID: 26946357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells.
    Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Zhou SF; Qiu JX
    Drug Des Devel Ther; 2015; 9():5511-51. PubMed ID: 26491260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion.
    Sun L; Liang J; Wang Q; Li Z; Du Y; Xu X
    Cell Prolif; 2016 Oct; 49(5):628-35. PubMed ID: 27571935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma.
    Zhou Y; Zhang L; Pan H; Wang B; Yan F; Fang X; Munnee K; Tang Z
    PLoS One; 2015; 10(4):e0123208. PubMed ID: 25915207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-183 Modulates Cell Apoptosis and Proliferation in Tongue Squamous Cell Carcinoma SCC25 Cell Line.
    Yan D; Cai X; Feng Y
    Oncol Res; 2016 Oct; 24(6):399-404. PubMed ID: 28281960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.